Does St. John's wort interfere with the antiandrogenic effect of oral contraceptive pills?

Contraception

Volumn 74, Issue 3, 2006, Pages 245-248

  Fogle, Robin H ^a   Murphy, Patricia A ^b   Westhoff, Carolyn L ^c   Stanczyk, Frank Z ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Hirsutism; Hyperandrogenism; Oral contraceptive pills; P 450 enzyme; St. John's Wort

Indexed keywords

ANDROGEN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; HYPERICUM PERFORATUM EXTRACT; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; HIRSUTISM; HORMONE DETERMINATION; HUMAN; HYPERICUM PERFORATUM; IMMUNOASSAY; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; WILCOXON SIGNED RANKS TEST;

ACNE VULGARIS; ADOLESCENT; ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; ETHINYL ESTRADIOL; FEMALE; HIRSUTISM; HUMANS; HYPERICUM; NORETHINDRONE; SEX HORMONE-BINDING GLOBULIN; SINGLE-BLIND METHOD; TESTOSTERONE;

EID: 33747000809     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.03.015     Document Type: Article

References (32)

1. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 101 (2003) 995-1007
2. Azziz R., and Gay F. The treatment of hyperandrogenism with oral contraceptives. Semin Reprod Endocrinol 7 (1989) 246-254
3. Venturoli S., Porcu E., Gammi L., et al. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence. Acta Eur Fertil 19 (1988) 129-134
4. Givens J.R., Andersen R.N., Wiser W.L., Umstot E.S., and Fish S.A. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. Am J Obstet Gynecol 124 (1976) 333-339
5. Cassidenti D.L., Paulson R.J., Serafini P., Stanczyk F.Z., and Lobo R.A. Effects of sex steroids on skin 5 alpha-reductase activity in vitro. Obstet Gynecol 78 (1991) 103-107
6. Giwa-osagie O.F., and Levell M. Sex hormone binding globulin levels in hirsute patients: the effect of combined OCs. Contracept Deliv Syst 3 (1982) 155-160
7. Breitkopf D.M., Rosen M.P., Young S.L., and Nagamani M. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism. Contraception 67 (2003) 349-353
8. Mastorakos G., Koliopoulos C., and Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 77 (2002) 919-927
9. Cullberg G., Hamberger L., Mattsson L.A., Mobacken H., and Samsioe G. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand 64 (1985) 195-202
10. Fogle R.H., Murphy P.A., Westhoff C.L., and Stanczyk F.Z. Lawrence review of natural products (1997), St. John's Wort. Facts and Comparisons, St. Louis
11. Hammerness P., Basch E., Ulbricht C., et al. St. John's Wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 44 (2003) 271-282
12. Roby C.A., Kantor E., Anderson G.D., and Burstein A.H. St. John's Wort impact on CYP3A4 activity. Proceedings of the 39th Annual Meeting, New Clinical Drug Evaluation Unit, June, Boca Raton, FL (Poster #129) (1999)
13. Ernst E. Second thoughts about safety of St. John's Wort. Lancet 354 (1999) 2014-2016
14. Markowitz J.S., Donovan J.L., and DeVane C.L. Effect of St. John's Wort on drug metabolism by induction of cytochrome p450 3A4 enzyme. JAMA 290 (2003) 1500-1504
15. Murphy P.A., Kern S.E., Stanczyk F.Z., and Westhoff C.L. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity, and breakthrough bleeding. Contraception 71 (2005) 402-408
16. Hall S.D., Wang Z., Huang S., et al. The interaction between St. John's Wort and an oral contraceptive. Clin Pharmacol Ther 74 (2003) 525-535
17. Pfrunder A., Schiesser M., Gerber S., Haschke M., Bitzer J., and Drewe J. Interaction of St. John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol 56 (2003) 683-690
18. Schwarz U.I., Buschel B., and Kirch W. Unwanted pregnancy on self-medication with St. John's Wort despite hormonal contraception. Br J Clin Pharmacol 55 (2003) 112-113
19. Goebelsmann U., Bernstein G.S., Gale J.A., et al. Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow I.H., and Crozier R. (Eds). Vasectomy: immunologic and pathophysiologic effects in animals and man (1979), Academic Press, New York 165-181
20. Goebelsmann U., Arce J.J., Thorneycroft I.H., Goebelsmann U., Arce J.J., Thorneycroft I.H., and Mishell Jr. D.R. Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration. Am J Obstet Gynecol 119 (1974) 445-452
21. Goebelsmann U., Horton R., Mestman J.H., et al. Male pseudohermaphroditism due to testicular 17β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 36 (1973) 867-879
22. Serafini P., Ablan F., and Lobo R.A. 5α-Reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab 60 (1985) 349-355
23. Narang R., Rao J., Savjani G., Peterson J., Gentzschein E., and Stanczyk F.Z. Radioimmunoassay kit for the quantitative measurement of androstanediol glucuronide in unextracted serum. Presented at the 17th National Meeting of the Clinical Ligand Assay Society, April 10-13, Chicago, IL (Poster #12) (1991)
24. Sodergard R., Backstrom T., Shanbag V., and Cartensen H. Calculations of free and bound fractions of testosterone and 17β-estradiol to human plasma proteins at body temperature. J Steroid Biochem Mol Biol 16 (1982) 801-810
25. Vermeulen A., Verdonck L., and Kaufman J.M. A critical evaluation of simple methods for estimation of free testosterone in serum. J Clin Endocrinol Metab 84 (1999) 3666-3672
26. Rinaldi S., Geay A., Dechaud H., et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 11 (2002) 1065-1071
27. Moore L.B., Goodwin B., Jones S.A., et al. St. John's Wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97 (2000) 7500-7502
28. Wentworth J.M., Agostini M., Love J., Schwabe J.W., and Chatterjee V.K. St. John's Wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 166 (2000) R11-R16
29. Lee D.W., and Park K.H. Testosterone metabolism by microsomal cytochrome P-450 in liver of rats treated with some inducers. Int J Biochem 21 (1989) 49-57
30. Sivapathasundaram S., Magnisali P., Coldham N.G., Howells L.C., Sauer M.J., and Ioannides C. Cytochrome P450 expression and testosterone metabolism in the liver of deer. Toxicology 187 (2003) 49-65
31. Maenpaa J., Pelkonen O., Cresteil T., and Rane A. The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol 44 (1993) 61-67
32. Cheng K.C., and Schenkman J.B. Testosterone metabolism by cytochrome P-450 isozymes RLM3 and RLM5 and by microsomes. Metabolite identification. J Biol Chem 258 (1983) 11738-11744